PTGS2 and malignant colon neoplasm: Nonsteroidal anti-inflammatory drugs and selective COX-2 inhibitors have been recognized as agents that may influence colon cancer progression [36], and observational studies have shown that usage of COX-2 inhibitors in colorectal cancer lowers risk of recurrence [37].